SPERO THERAPEUTICS INC's ticker is SPRO and the CUSIP is 84833T103. A total of 80 filers reported holding SPERO THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $561,006 | -17.3% | 463,641 | -0.9% | 0.00% | – |
| Q2 2023 | $678,543 | -86.7% | 467,960 | -20.2% | 0.00% | -100.0% |
| Q1 2022 | $5,104,000 | -12.3% | 586,642 | +61.4% | 0.00% | 0.0% |
| Q4 2021 | $5,819,000 | -16.2% | 363,534 | -3.6% | 0.00% | 0.0% |
| Q3 2021 | $6,941,000 | +13.3% | 377,095 | -14.1% | 0.00% | 0.0% |
| Q2 2021 | $6,126,000 | -4.3% | 438,837 | +0.9% | 0.00% | 0.0% |
| Q1 2021 | $6,401,000 | +24.4% | 434,788 | +63.8% | 0.00% | 0.0% |
| Q4 2020 | $5,147,000 | +1674.8% | 265,441 | +1137.3% | 0.00% | – |
| Q2 2020 | $290,000 | – | 21,454 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 3,932,209 | $76,246,000 | 15.85% |
| Atlas Venture Associates XI, LLC | 1,376,968 | $26,700,000 | 4.23% |
| Atlas Venture Associates IX, LLC | 1,376,968 | $26,700,000 | 4.23% |
| BVF INC/IL | 2,243,278 | $43,497,000 | 1.71% |
| AWM Investment Company, Inc. | 372,755 | $7,228,000 | 0.92% |
| Alphabet Inc. | 889,979 | $17,257,000 | 0.83% |
| Rock Springs Capital Management LP | 1,235,000 | $23,947,000 | 0.51% |
| Novo Holdings A/S | 576,702 | $11,182,000 | 0.48% |
| Artal Group S.A. | 500,000 | $9,695,000 | 0.21% |
| Granahan Investment Management | 420,320 | $8,150,000 | 0.18% |